Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 20 of 7861 for:    "Kidney Diseases"

Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02155127
Recruitment Status : Completed
First Posted : June 4, 2014
Last Update Posted : November 18, 2016
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Patricia Painter, University of Utah

Brief Summary:
Chronic kidney disease (CKD) affects more than 26 million individuals (13 percent) of the U.S. population, with a projected 70 percent increase by the year 2015 to over 40 million individuals. Impairments in physical function and mobility limitations have been reported in older Chronic Kidney Disease patients, however the consequences of impaired functioning on participation in daily life and quality of life have not been studied. Early identification and interventions to mitigate deterioration in physical function and mobility should lead to improved health and quality of life outcomes in older patients with Chronic Kidney Disease. Although older individuals with Chronic Kidney Disease have reduced survival expectancy, maintaining physical function and mobility may contribute to longer active life expectancy, and higher quality of life despite their diagnosis.

Condition or disease Intervention/treatment Phase
Chronic Kidney Disease Behavioral: walking Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study
Study Start Date : October 2014
Actual Primary Completion Date : October 2016
Actual Study Completion Date : October 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Diseases

Arm Intervention/treatment
Experimental: walking intervention
Subjects are randomized to walking/functional strength program with weekly coaching or usual care. The program is for 12 weeks. The intervention includes 3 lower extremity strengthening exercises, and progressive walking.
Behavioral: walking
No Intervention: usual care
these subjects receive information on walking program, however do not receive any coaching over 12 weeks



Primary Outcome Measures :
  1. walking speed [ Time Frame: baseline to 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female patients over the age of 60 years
  • Diagnosed with moderate to severe CKD (stage 2-4)
  • Ambulatory (with or without use of an assistive device such as a cane or walker)
  • Living in the community, cognitively able to provide consent and understand directions for the tests
  • Cognitive ability to understand and carry out an independent home walking program
  • Access and ability to communicate with study staff on a weekly basis and available for follow-up testing.

Exclusion Criteria:

  • Inability to carry out a program of walking independently at home
  • Unavailable for follow-up testing, estimated GFR >60 ml/minx1.73m2 and < 15 ml/minx1.73 m2
  • Recent cardiac event (within the past 6 months)
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Pulmonary disease that may limit the ability to progress with walking
  • Progressive neuromuscular disease
  • Any orthopedic or neuromuscular condition that may be exacerbated by increased walking activity
  • diabetic foot ulcer.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02155127


Locations
Layout table for location information
United States, Utah
University of Utah
Salt Lake City, Utah, United States, 84112
Sponsors and Collaborators
University of Utah
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Layout table for investigator information
Principal Investigator: Patricia L Painter, Ph.D. University of Utah

Layout table for additonal information
Responsible Party: Patricia Painter, Associate Research Faculty, University of Utah
ClinicalTrials.gov Identifier: NCT02155127     History of Changes
Other Study ID Numbers: IRB_00064407
First Posted: June 4, 2014    Key Record Dates
Last Update Posted: November 18, 2016
Last Verified: November 2016

Keywords provided by Patricia Painter, University of Utah:
chronic kidney disease
physical function

Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency